Blood-Based Mutation Testing: Circulating Tumor Cells and Tumor DNA

Gaining multi-dimensional insights into cancer heterogeneity: Co-analysis of CTCs and ctDNA...Подробнее

NCCM 2024 | Analytical & Clinical Validation Circulating Tumor DNA-based AssayПодробнее

Circulating tumor DNA: a new frontier in colorectal cancer -- Dr. Stacey CohenПодробнее

Innovative ctDNA-based liquid biopsy techniques for cancer diagnosisПодробнее

WCR Updates Webinar Series - Liquid Biopsy-Based Biomarkers for Cancer Detection and MonitoringПодробнее

Why Tumor DNA Sequencing (Tissue-Based) 🧬 is Critical for the Most Effective Cancer Treatment 🩺Подробнее

Why Liquid Biopsy🩸 Tumor DNA Sequencing is Critical for the Most Effective Cancer TreatmentПодробнее

Galleri Test versus Circulating Tumor DNA Test: A Cancer Doctor ExplainsПодробнее

Emerging Role of Circulating Tumor DNA in the Management of Thoracic Malignancies (Sept. 26, 2024)Подробнее

Blood test may identify patients with non-small cell lung cancer subtype who can benefit from co...Подробнее

Emerging Role of Circulating Tumor DNA in GISTПодробнее

Dr Rebecca Lee Talks about Biomarkers at Melanoma Patient Conference 2022Подробнее

Grand Round 19/10/2022 - Circulating Tumor DNA and germline testing in breast cancerПодробнее

Cell‐Free DNA Sequencing for Early Cancer DetectionПодробнее

22 Principles of Biomarker Testing: Part 2 The Liquid BiopsyПодробнее

Biomarkers Lighting the WayПодробнее

Real-world monitoring of circulating tumor DNA to predict cancer recurrenceПодробнее

Circulating tumor DNA (ctDNA) testing, a type of liquid biopsyПодробнее

Liquid Biopsy in Oncology: Opportunities and ChallengesПодробнее

Be Inspired: The Genetics of Cancer: Part 2 - Exploring Genetic Testing and the Path to TreatmentПодробнее